Intec pharma stock
Nettet3. aug. 2024 · Immediately following closing of the Decoy merger there are approximately 5,405,963 shares of Indaptus common stock outstanding, with pre-merger Decoy … Nettet4. aug. 2024 · Immediately following closing of the Decoy merger there are approximately 5,405,963 shares of Indaptus common stock outstanding, with pre-merger Decoy …
Intec pharma stock
Did you know?
Nettet1. apr. 2024 · Get the latest news and real-time alerts from Intec Pharma Ltd (NTEC) stock at Seeking Alpha. Seeking Alpha - Go to Homepage Entering text into the input … NettetINTEC PHARMA LTD (TLV:NTEC) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share INTEC PHARMA LTD TEL AVIV STOCK EXCHANGE: …
Nettet16. mar. 2024 · March 16, 2024 - 8:18 pm. JERUSALEM , March 16, 2024 (GLOBE NEWSWIRE) -- Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that it has filed its annual report on Form 10-K for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission.A copy of the annual … Nettet29. okt. 2024 · Intec Pharma Ltd. Oct 29, 2024, 08:00 ET JERUSALEM, Oct. 29, 2024 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") …
Nettet29. jul. 2024 · Intec Pharma also saw 34 million shares trading hands against the daily average of less than 1 million. There’s a lot to unpack in regard to NTEC’s short … NettetINTEC PHARMA LTD : Stock Market News and Information NTEC IL0011177958 MarketScreener Homepage Equities Israel TEL AVIV STOCK EXCHANGE Intec …
Nettet29. jul. 2024 · Intec Pharma Ltd (NTEC) shares soared 19.89% in after-hours on Wednesday, July 28, 2024, and closed the daily trading at $10.97 per share. Earlier in the regular trading hours, NTEC’s stock gained 1.10%. NTEC shares have fallen 74.09% over the last 12 months, and they have moved down 36.81% in the past week.
Nettet12. mai 2024 · JERUSALEM, Aug. 3, 2024 /PRNewswire/ -- Intec Parent, Inc. (NASDAQ: NTEC) (" Intec Parent " or the "Company"), today announced that the pending and previously announced reverse merger (the "Decoy Merger") with Decoy Biosystems, Inc. ("Decoy") is currently expected to close after market hours today, Tuesday, August 3, … schedule iii of the companies act 2013 mcaNettetIntec Pharma Ltd. (NTEC.TA) Stock Price, News, Quote & History - Yahoo Finance Yahoo Finance Plus U.S. markets open in 4 minutes Nasdaq Futures Russell 2000 … schedule iii to the companies act 2013NettetFind real-time INDP - Indaptus Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. schedule ii medicationsNettet3. aug. 2024 · Immediately following closing of the Decoy merger there are approximately 5,405,963 shares of Indaptus common stock outstanding, with pre-merger Decoy shareholders owning approximately 65.6% and... schedule iii-v controlled substances listNettet26. jul. 2024 · Pursuant to the securities purchase agreement entered into by and between Intec US and the investor, Intec US will issue 10,909,091 (or 2,727,273 on a post-split … schedule ii medications are also calledNettet17. aug. 2024 · Intec Pharma Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services. Click here for our free guide on … schedule ii mental health medicationsNettet26. jul. 2024 · Pursuant to the securities purchase agreement entered into by and between Intec US and the investor, Intec US will issue 10,909,091 (or 2,727,273 on a post-split basis) shares of its common... schedule iii rounding off requirement